Delivery Order SPE2DB22D1002-SPE2DB24FLGM5

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,132.30, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of June 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order contract has a ceiling value of $20,371.16 and a completion date of August 28, 2024. Amerisourcebergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide essential medical commodities, including...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract, valued at $1,993.19, is a Firm Fixed Price Delivery Order with a completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award, valued at $11,235.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical product, and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a total ceiling value of $11,336.56. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has a ceiling value of $9,363.10 and is a firm fixed price, definitive contract. It has an ultimate completion date of September 16, 2024. This contract is not set aside for any specific business type. AmerisourceBergen, through its Corporate Office division, has been awarded...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $37,452.40 for the supply of 4563971703 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to military treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, for TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has a ceiling value of $8,606.89 and runs through August 12, 2024. It is a firm fixed price contract with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products. The firm fixed price delivery order, valued at $49,761.15, has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award and has received numerous prior contracts from DLA Troop Support...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a ceiling value of $3,453.16 and a completion date of June 11, 2025. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor for this...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLGM5
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical product. The award is a Firm Fixed Price Delivery Order with a ceiling value of $23,407.75 and a completion date of August 15, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to supply the specified pharmaceutical product to support various government healthcare programs and military treatment facilities. The contract is not set aside for a particular business type. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued at up to $999,999,999 and $750,000 respectively, to provide a range of medical commodities and prescription drugs to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/13/24, 9:08 AM